Compare STRO & PDLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STRO | PDLB |
|---|---|---|
| Founded | 2003 | 1960 |
| Country | United States | United States |
| Employees | 133 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 524.8M | 423.3M |
| IPO Year | N/A | 2021 |
| Metric | STRO | PDLB |
|---|---|---|
| Price | $25.43 | $18.56 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $31.33 | N/A |
| AVG Volume (30 Days) | ★ 255.3K | 39.2K |
| Earning Date | 05-11-2026 | 04-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 160.87 |
| EPS | N/A | ★ 0.36 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $51.64 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.67 | $12.85 |
| 52 Week High | $43.85 | $18.65 |
| Indicator | STRO | PDLB |
|---|---|---|
| Relative Strength Index (RSI) | 30.61 | 68.49 |
| Support Level | $23.43 | $17.25 |
| Resistance Level | $27.96 | N/A |
| Average True Range (ATR) | 3.47 | 0.32 |
| MACD | -1.79 | 0.08 |
| Stochastic Oscillator | 0.40 | 83.71 |
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.